Clinical Trials Logo

Clinical Trial Summary

Susac Syndrome is a rare disease and the establishment of the diagnosis is often difficult. The aim of this investigation is to identify relevant biomarkers and to elucidate the pathogenesis of Susac syndrome


Clinical Trial Description

Susac Syndrome is a rare disease characterized by encephalopathy, branch retinal artery occlusion and sensorineural deafness. The pathogenesis is not yet clear, an autoimmune endotheliopathy is discussed. Because of the variable and often incomplete clinical presentation, the establishment of the diagnosis is often delayed or even completely missed. The aim of this study is to identify biomarkers that facilitate the reliable and prompt establishment of the diagnosis. Patients with a definite diagnosis of Susac syndrome and healthy subjects as controls are investigated. Furthermore, the correlation of serological markers with structural retinal and cerebral changes will contribute to clarification of the pathogenesis of Susac syndrome. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01273792
Study type Observational
Source Charite University, Berlin, Germany
Contact Jan M Dörr, MD
Phone +49 30 450
Email jan-markus.doerr@charite.de
Status Recruiting
Phase
Start date May 2010
Completion date December 2021

See also
  Status Clinical Trial Phase
Completed NCT06349603 - Physiotherapy Approach for Susac Syndrome